ResultsIQ

ResultsIQ › Latest results › J.G.Chemicals Limited

J.G.Chemicals Limited Q2 FY26 earnings call summary

NSE: JGCHEM · BSE: 544138

Earnings call of 17 Nov 2025, summarised by AI from the filing.

Non-rubber applications (pharma, cosmetics, ceramics) growing; share to rise from 15% to over 30%.

Key takeaways

  1. Driver Non-rubber applications (pharma, cosmetics, ceramics) growing; share to rise from 15% to over 30%.
  2. Risk Sharp zinc price swings can impact margins short-term.

Original filing on BSE

J.G.Chemicals Limited Q1 FY27 results

As filed: Revenue ₹316 cr (+45% year on year), EBITDA ₹33.5 cr (+68% year on year), PAT ₹26.1 cr (+63% year on year), EBITDA margin 10.6% (+145 bps).

The Q1 FY27 score, against the company's own trend, is for premium members.

Earlier results and the share price after them

  • Q4 FY26: Revenue ₹286 cr (+28% year on year), EBITDA ₹21.5 cr (+13% year on year), PAT ₹18.9 cr (+18% year on year), EBITDA margin 7.5% (−98 bps). Score 77 of 100, Above trend. Revenue and profit growth were well above the company's own trend; EBITDA growth was above it. EBITDA margin fell 98 bps year on year. Share price after the results: +3.1% in 29 days (Nifty 500: −0.1%).
  • Q3 FY26: Revenue ₹248 cr (+19% year on year), EBITDA ₹22.8 cr (+4% year on year), PAT ₹18.4 cr (+2% year on year), EBITDA margin 9.2% (−136 bps). Score 45 of 100, In line with trend. EBITDA margin fell 136 bps year on year. Not enough history for a trend yet: scored on growth alone. Share price after the results: −12.6% in 30 days (Nifty 500: −7.8%).
  • Q2 FY26: Revenue ₹220 cr (+4% year on year), EBITDA ₹17.0 cr (−19% year on year), PAT ₹15.0 cr (−12% year on year), EBITDA margin 7.7% (−218 bps). Score 24 of 100, Below trend. EBITDA margin fell 218 bps year on year. Not enough history for a trend yet: scored on growth alone. Profit fell 6% from last quarter. Share price after the results: −11.1% in 28 days (Nifty 500: −0.5%).
  • Q1 FY26: Revenue ₹218 cr (+7% year on year), EBITDA ₹20.0 cr (−9% year on year), PAT ₹16.0 cr (0% year on year), EBITDA margin 9.2% (−166 bps). Score 27 of 100, Below trend. EBITDA margin fell 166 bps year on year. Consolidated profit +0% but standalone +50%. Not enough history for a trend yet: scored on growth alone. Share price after the results: +0.9% in 30 days (Nifty 500: +1.9%).
  • Q4 FY25: Revenue ₹224 cr (+24% year on year), EBITDA ₹19.0 cr (+12% year on year), PAT ₹16.0 cr (+14% year on year), EBITDA margin 8.5% (−91 bps). Score 57 of 100, In line with trend. EBITDA margin fell 91 bps year on year. Not enough history for a trend yet: scored on growth alone. Profit fell 11% from last quarter. Share price after the results: +11.5% in 30 days (Nifty 500: +1.0%).
  • Q3 FY25: Revenue ₹209 cr, EBITDA ₹22.0 cr, PAT ₹18.0 cr, EBITDA margin 10.5%. Not scored. No consolidated results for the same quarter last year to compare yet (consolidated revenue ₹209 cr). Scored once a year-earlier consolidated quarter exists.
  • Q2 FY25: Revenue ₹212 cr, EBITDA ₹21.0 cr, PAT ₹17.0 cr, EBITDA margin 9.9%. Not scored. No consolidated results for the same quarter last year to compare yet (consolidated revenue ₹212 cr). Scored once a year-earlier consolidated quarter exists.

Past price moves after results do not indicate future moves. Not a recommendation.

J.G.Chemicals Limited earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.